Theratechnologies to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2021
Theratechnologies Inc. (THTX) announced it will report financial results for its fourth quarter and full fiscal year 2021 on February 24, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies Inc. (THTX) announced it will report financial results for its fourth quarter and full fiscal year 2021 on February 24, 2022. A conference call will take place at 8:30 a.m. ET the same day, hosted by CEO Paul Lévesque, to discuss these results and recent business updates. Investors can participate by dialing the provided numbers or accessing the webcast. An audio replay will be available later that day. Theratechnologies focuses on innovative therapies to address unmet medical needs.
Positive
- Upcoming financial results reporting could indicate potential growth opportunities.
- Conference call allows for direct communication between management and investors.
Negative
- None.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was -1.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced today that it will report financial results for its fourth quarter of fiscal 2021 ended November 30, 2021 as well as for its full fiscal year 2021 on Thursday, February 24, 2022.
A conference call will be held on February 24, 2022 at 8:30 a.m. (ET) to discuss the results and recent business updates. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque and other members of the management team will be available to answer questions from participants following prepared remarks.
The conference call can be accessed by dialing 1-844-400-1697 (toll free) or 1-703-736-7400 (International). The conference call will also be accessible via webcast at https://edge.media-server.com/mmc/p/thbammaz. An audio replay of the conference call will be available on the same day starting at 11:30 a.m. (ET) until March 3, 2022 by dialing 1-855-859-2056 (North America) or 1-404-537-3406 (International) and by entering the access code: 8659715. An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For investor and media inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
514 336-7800
communications@theratech.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.